SEC Info - BlackRock Inc. - ‘SC 13G/A’ on 7/8/22 re: Tonix Pharmaceuticals Holding Corp.

SEC Info℠

Home

Help

Please Sign In

BlackRock Inc. – ‘SC 13G/A’ on 7/8/22 re: Tonix Pharmaceuticals Holding Corp.

On: Friday, 7/8/22, at 4:52pm ET · Accession #: 834237-22-10170 · File #: 5-86436

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/08/22  BlackRock Inc.                    SC 13G/A               1:12K  Tonix Pharmas Holding Corp.       Blackrock Global Al… Inc

Amendment to Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G — WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Amendment to Statement of Acquisition of               6±    21K 
                Beneficial Ownership by a "Passive" Investor

Filing Submission 0000834237-22-010170 – SGML Text

Original SGML Text submitted by:	Blackrock Global Allocation Fund, Inc. (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 12K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20220708-165311	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20220708-165307	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20220708-165219	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0000834237-22-010170
<TYPE>				SC 13G/A
<PUBLIC-DOCUMENT-COUNT>		1
<FILING-DATE>			20220708
<DATE-OF-FILING-DATE-CHANGE>	20220708

<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>		Tonix Pharmaceuticals Holding Corp.
<CIK>				0001430306
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			261434750  ⇒ 26-1434750 or 261-43-4750
<STATE-OF-INCORPORATION>	NV
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC 13G/A
<ACT>				34
<FILE-NUMBER>			005-86436
<FILM-NUMBER>			221074894
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			26 MAIN STREET, SUITE 101
<CITY>				CHATHAM
<STATE>				NJ
<ZIP>				07928
<PHONE>				212-980-9155
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			26 MAIN STREET, SUITE 101
<CITY>				CHATHAM
<STATE>				NJ
<ZIP>				07928
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		TAMANDARE EXPLORATIONS INC.
<DATE-CHANGED>			20080320
</FORMER-COMPANY>
</SUBJECT-COMPANY>

<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>		BlackRock Inc.
<CIK>				0001364742
<ASSIGNED-SIC>			6211
<IRS-NUMBER>			320174431  ⇒ 32-0174431
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC 13G/A
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			55 EAST 52ND STREET
<CITY>				NEW YORK
<STATE>				NY
<ZIP>				10055
<PHONE>				212-810-5300
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			55 EAST 52ND STREET
<CITY>				NEW YORK
<STATE>				NY
<ZIP>				10055
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		BlackRock, Inc.
<DATE-CHANGED>			20060929
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		New BlackRock, Inc.
<DATE-CHANGED>			20060601
</FORMER-COMPANY>
</FILED-BY>

<DOCUMENT>
<TYPE>		SC 13G/A
<SEQUENCE>	1
<FILENAME>	us8902608624_071122.txt
<TEXT>
       Show <TEXT>: 322 lines (widest: 79 characters) - 11K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0000834237-22-010170 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

BlackRock Inc. – ‘SC 13G/A’ on 7/8/22 re: Tonix Pharmaceuticals Holding Corp.

On: Friday, 7/8/22, at 4:52pm ET · Accession #: 834237-22-10170 · File #: 5-86436

Previous ‘SC 13G’: ‘SC 13G/A’ on 7/8/22 · Next: ‘SC 13G’ on 7/8/22 · Latest: ‘SC 13G/A’ on 5/10/24

Amendment to Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G — WA’68Filing Table of Contents

Amendment to Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G — WA’68

Filing Table of Contents